mTOR Inhibition for Relapsed or Refractory Hodgkin Lymphoma: Promising Single Agent Activity with Everolimus (RAD001).
| Autor: | Johnston, Patrick B. *, Ansell, Steven M., Colgan, Joseph P., Habermann, Thomas M., Inwards, David J., Micallef, Ivana N.M. *, Porrata, Luis F., Reeder, Craig B., Roy, Vivek, LaPlant, Betsy R. *, Witzig, Thomas E. |
|---|---|
| Zdroj: | In Blood 16 November 2007 110(11):2555-2555 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|